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A synth~li¢ pcplid¢ con'espondin$ to xin¢ finger ;!1 of the Xenopus protein Xfin adapts a folded conformation in the prewnce of xtn~. The same 
Peptide in 11~e ab..~n¢¢ of xin¢ is not folded in a stable t¢rtiary conformation, as delermir~d by NMR. Btndin$ experiment.= have ~hown that the 
I~plidc binds non.sra:cifically to DNA only in the presence of zinc. Moreover. eorapetitive DNA bindinll experiments Indicate interaction with 
3,9 :t: 0.4 base p, irs. 
Zim: fin|or; DNA,bindinll; 2D NMi~ 
1. INTRODUCTION 
Zinc fingers represent an important structural motif 
found in a large family of" eukaryotic transcriptional 
regulatory proteins [!=3]. Transcription factor IIIA 
(TFIIIA) isolated from Xenopus laevis [4,5] was the 
first protein to be identified as a zinc finger protein. It 
=s now apparent that there are different classes of zinc 
fingers; this paper is focused on fingers of the TFIIIA 
type where the zinc is coordinated by two Cys and two 
His ligands. Circular dichroism and NMR spectroscopy 
have been used to demonstrate the folding of single zinc 
fingers from TFIIIA [6], ADRI [7-9], Xfin [10,11], and 
SWI5 [12]. The folding mad the formation of a stable 
tertiary structure for these peptides depends on the 
presence of Zn z* [6-12]. 
The "rFIIIA protein contains nine zinc finger motifs 
with 7-11 zinc atoms per molecule [5]. Zinc is proposed 
to be coordinated to each of the nine finger motifs, for- 
ming an independently folded domain. However, recent 
reports cast doubts upon the role of zinc in stabilization 
of the folded zinc finger structure. Studies by Wu and 
co-workers uggest hat only two reel of zinc/reel of 
TFIIIA protein are required to maintain the correct 
conformation for sequence-specific binding to either 
DNA or 5 S RNA [13,14], In addition, Roesch and 
coworkers recently reported structural studies of a syn- 
thetic 30-residue zinc finger peptide corresponding to
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the seventh finger domain from the mouse Kruppehlike 
gone mKr2 [15], with the surprising finding that the 
peptide 'clearly possesses a well defined tertiary struc- 
ture' in the absence of zinc, The solution structure pro- 
posed for zinc-free mKr2 differs significantly from the 
three.dimensional structure of the Xfin-31 [10] and 
ADRIb [9] zinc fingers, 
At present he [iterat.ure contains conflicting reports 
concerning the exact role of the zinc in dictating both 
three.dimensional structure and interactions with 
DNA, In view of this, we undertook a direct com- 
parison of the same zinc finger peptide, corresponding 
to finger 31 of the protein Xfin [16,17] in the absence 
and presence of Zn 2. to clarify the ambiguity surroun- 
ding the role of the metal, The present work and the 
work reported earlier [10,11] show unequivocally that 
the Xfin-31 zinc finger peptide is folded in a stable ter- 
tiary conformation only in the presence of Zn 2÷. In the 
absence of Zn 2÷ the peptidc does not show stable ter- 
tiary structure detectable by NMR. Furthermore, there 
is no detectable binding of the Xfin-31 peptid¢ to DNA 
in the absence of Zn 2+ but non-specific binding occurs 
when Zn 2+ is present. 
2. MATERIALS AND METHODS 
2, I. Peptide preparation 
The Xfin-31 peptide (Ac.YKCGLCERSFVEKSALSRHQRVHK. 
N-NH2) was synthesized as described previously [1 I], Prior to in jet. 
tion of the sample for HRLC, the peptide was treated with excess 
dithiothreitol (DTT) to reduce any disulfide bridBed forms. The 
purified sample was l~ophillzed and stored under argon at -20°C,  
The sample used for binding assays and NMR studies was >95o7o pure 
as determined by analytical HPLC, The peptide concentration was 
determined by measurement of tyrosine absorbance in 6 M guanidin¢ 
hydrochloride at 275.5 nm (e.ss  - 1450 M-t ,cm -I) [18,19l, The 
contribution to the absorbance by the two cysteine residues was also 
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w~ prepared by I~ previously ¢l~wll~d procedure [ll], 
2.2, DN.*t re , /~td¢  bi~dtn~ ayx 
Two dirferem do.bte ~lr~ndod eoxyoligonu¢l¢otlde~ were) tyn. 
thesl~ed with )In Applied Biosy)lem~ DNA Symheslxer blod~l 3~OB. 
The dnllle ttr~nded oll$onucleotlde~ were debloeked overnlgh! if) 
aqueou~ ammonia (0,$ M) and ilel purified, Aliquots of th~ ~lr)tlN 
)strinded oli|onueNotlde~ were la~elcd ~t ehe S' end with [)-)'PJATP 
and polym~leolld~ kin=so prior to renatur~tlon with nn exee~ or 
unlabeled oU|onud0otide, Eq~)=l amounts or each complementary 
strand (¢s¢lmated from UV ~bsotbanee] were mixed h~ 0,1 M .~odium 
carbonate buffer, pH T.$, heated to 95"C and .glowed [o hybridize by 
slow ¢ooli~g to 22'C, Tl~e DNA sequencer used were: 
$ S 26,mer (C,bloek): 5' GATCTACrTGGATGGGAGACCGCCTG 3' 
B,blo~k 24,mer: $' GATCOATGGTTCGAATCCATCCTC 3' 
wbere the sequence or only one strand is given. In addition, a ~0 base 
pair £eoRl./ilndlll polylinker fragmen¢ from pUCI9 was u~ed as a 
non.specific DNA, For some experlmems, the double ~randed 
material was gel.purified prior to performing pepttde bindinll ex. 
perimems, Oligonu¢10otldes were concentrated by ethanol preelplta. 
lion and restlspended in binding burrer (see below). An aliquot was 
taken for measurement of DNA concentration by UV absorbnnce us. 
ing an extinction coefficient of I ODes.., - 50/,g/ml, 
2.3. Gel mobility shelf assoy~ for peplide-DNA complexes 
DNA binding studies of Xfindt peptide were carried out in a bur. 
for containing 10 mM Tris.HCI (pH "/,5), 5 mM MgCI=, 50 mM NaCI, 
t0% (v/v) illycerol with 0,5- ! n8 of labeled double stranded synthetic 
oligonucleotides and various amounts of unlabded poly dl.poly dC 
(10-500 ng, Pharmacies in a final volume of 10-20~1, Binding rent. 
lions were at 22"C rot 30-4S rain. Both the free peptide and the 
preformed zinc complex were used, The samples were loaded on a I 
ram-thick S% polyacrylamide gel (29:1 acrylamide to bisacrylamide) 
in 90 mM Tris-borate buffer, pH 8.3, and subject¢d to electrophoresis 
at 125-150 V (8-10 V/cm) for 2,S to 3.~ h, The gels were pro. 
electrophoresed at 150 V for I h prior to electrophoresis The labeled 
DNA was visualized by autoradiography and the peplide.bound and 
free DNA was quantitated by liquid scintillation counting of gel slices 
obtained with the aid of the autoradiogram 
2,4. NMR rtleasurements 
Zinc-free Xfin.31 was prepared as a 4 mM solution in 90% 
H=O/lO~o =H=O and in =H=O at pH 4.15 and =H=O at pH 4.4, Care 
was taken to prevent oxidation and disulfide bridge formation while 
preparing the sample for the NMR experiments, All solvents were 
purged with argon and all transfers were carried out under argon, The 
~H NMR spectra were recorded at 278 K using a Bruker AMS00 spec- 
trometer, Data processing was carried out on CONVEX C120 and 
C240 computers using software provided by Dr Dennis Hare 
All of the NMR data described here refers to the zlnc-free Xfin-31 
peptide (see [10,11] for NMR studies of the zinc complex), Two. 
dimensional NMR spectra were recorded in the phase.sensitive mode 
with quadrature detection in the (~ dimension using time. 
proportional phase incrementation [21,22], Spectra were recorded 
with the carrier placed on the ~HzO or HOD resonances, Double 
quantum filtered COSY (DQF.COSY) spectra were acquired using 
the standard pulse sequence and phase cycling [23], Phase.sensitive 
NOESY spectra were acquired using standard methods [24] with 300 
and 500 ms mixing periods, 
Spectra were Fourier-transformed using a Lorentzian to Gaussian 
weighting function in the ~2 dimension and a shifted sine bell 
weighting function in ~=, Basellne-correction [2S] and t) ridge sup. 
pression [26] were used for cosine modulated experiments. For most 
experiments, the final spectrum contained 2048 real points in both 
dimensions 
3, RESULTS AND DISCUSSION 
Standard sequential assillnment prowdur~ (2"/I wore 
used to obtain spe¢tt"ic assi¢nments for the xinc.rre¢ 
Xf in.31 r~Plide. The dN)~(i,i+ l )  and d.)~(i,i + I~ so. 
quential NOE enhancements observed rot sine.free 
Xfin..31 are summ=ri~ed in Fig. ! along with a reprexen. 
tative :eglon of  the NOESY spectrum, A few very weak 
d .N( i , i+2)  and d .~( i , i+3)  NOE 's  are observed i .  
NOESY spectra recorded at very Ion= mixing times 
(rrn = 300 and 500 ms), These are indicative o f  a small 
populat ion of  helical and turn-l ike conformations in the 
zinc.free peptide. However, the weakness of these 
NOE's  and the dominance of  d.N(i , i  + 1) scqLlential 
NOE connectivities shows that the peptide is lar£ely un- 
folded in the absence o f  Zn =*. 
Secondary structure prediction [28] for X f in -3 l  pep- 
tide shows strong propensity for helical conformat ion 
for residues Cys-6 through Gln-2n. Overall. the secon- 
dary structure prediction torte;lares well with the ¢x- 
perimentai observation of  weak d.~(t , i+ 3) medium- 
range NOE's which indicate the presence o f  a smal l  
populat ion of helical conformers between Glu-7 and 
Gin.20 in the zinc-free peptide (Fig. 2), The dm~(i,i -I- 1) 
sequential NOE's  become weaker relative to the 
d,.N(i , i+ 1) HOE's  at both ends of  the peptide, sug- 
gesting that the helix is frayed and more disordered 
toward both termim, 
The NOE connectivities observed for the zinc- 
complexed peptide [I l] are notably different from those 
of  the zinc-free peptidc, The medium.range NOE's  
def in ing the helix are very much stronger in the presence 
of  Zn =* , are more extenswe, and occur in a different 
region of the sequence (Fig, 2). In contrast o the free 
peptide, the helix extends from residues 12-24 in the 
zinc complex. In the absence of  Zn z* the dNN(i,i + I) 
NOE 's  are weaker than the d .N( i , i - l )  NOE 's  
throughout the sequence (Fig. I), consistent with a low 
populat ion of helical conformers; for the zinc. 
complexed peptid¢ the dNN(i,i + I) NOE's  are stronger 
than the d.~{i,i + I) NOE's  (see Fig, 2 in  ref. 1 I) in the 
helical region, Circular dichroism measurements on 
related finger peptides confirm the presence of  helix in 
the presence of Zn z+ but fail to detect helix in the zinc- 
free peptides (unpublished observations on TF I I IA  
finger 5; see also [6,7]). Finally, many long-range 
NOE's  are observed for the zinc-complexed peptide be- 
tween residues distant in the polypeptide chain [10, l l]; 
no long-range NOE's  are observed  for the zinc-free 
peptide, even at a mixing time of 500 ms, 
Substantial changes occur in the NMR spectrum of 
the Xfin-31 peptide upon binding of Zn 2+. In the 
absence of Zn z÷, tH and t3C chemical shifts are very 
close to ' random coil' values (Lee, Palmer and Wright, 
manuscr ipt  in preparation). The dispersion of  the 
amide and the C%I  proton resonances increases con- 
siderably when Zn z+ is bound and several methyl, 
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Fig. 1, Finger print region of NOESY spectrum of zinc-free xfin.31 peptide in 90°70 HzO/10°7o 2H20 with summary of sequential NOE eonnec- 
tivities. Sequential (i)i + 1) NOE's are represented as hatched blocks. The height of the block is a qualitative measure of NOE intensity in the 
r., = 300 ms NOESY spectrum at 278K. 
aromatic, and amide proton resonances are shifted 
significantly relative to their: positions in the zinc-free 
peptide. These characteristic resonance shifts were 
observed for both Xfin-31 and finger 5 of TFIIIA [11] 
and are similar to those described by Klevit and co- 
workers for a synthetic zinc finger from ADR1 [7-9] 
r 
and Neuhaus and co-workers for fingers from SWI5 
[12]. In all cases, the finger peptides appear to fold only 
in the presence of  Zn 2÷. 
To investigate further the role of Zn 2+, DNA binding 
assays for Xfin-31 peptide in the presence and absence 
of Zn 2+ were carried out. Gel electrophoresis of labeled 
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Fig, 2, Comparison of medium range NOE's of (a) zinc.free Xfin-3 I 
atld (b) zinc.comploxed Xfin-3l at 278K. The NOESY spectra or the 
zinc-free Xfin-31 peptlde were measured with mixing times of 300 altd 
500 ms, Tl~e NOESY spectra of zin¢-comp]exed Xfin-31 were 
measured with mixing times of 1..(0 and 200 ms, The dasl~ed lines for 
the medium.range NOE's for zinc.free Xfin-31 indicate the much 
weaker intensities observed relative to the zinc.comple.~ced Xfin-31. 
Even at the longer mixing times used, the medium range NOE ilUen- 
sitlcs are much weaker for the zinc-free peptide 
DNA fragments under n~t~-denaturi'ng conditions [29] 
was used to monitor binding of the Zn 2+ finger peptides 
to small double stranded eoxyoligonucleotides. Since 
the binding site for Xfin is unknown [16], we used two 
oligonucleotides available in our laboratory. One of 
these corresponds to the major binding site for the RNA 
polymerase Ill transcription factor TF[IIC (B-block 
oligo) [30] and the other corresponds to part of the bin- 
ding site for the 5 S gone-specific transcription factor 
TFIIIA [4]. As TFIIIA is the prototype zinc finger pro- 
tein [5] and TFIIIC is also likely to be a zinc finger pro. 
tein since metal chelation with o-phenanthroline in- 
hibits TFII IC binding (E.P. Geiduschek, personal com. 
munication)~ these oligonucleotides seemed to be ap- 
propriate for assays of Xfin-31 peptide binding. Fig, 3 
shows the results of a titrmzon of the B-block 
oligonucleotide with Xfin-31 pc;~tide in the presence 
(lanes l to 4) and absence. (lanes 5 to 8) of Zn 2+. With 
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Fig, 3, Non-denaturing =el el~ctrophoresis showinlt Xrin.31 peptide 
binding to =t double ttranded d¢o,~yolijonucleot[d¢. Various amounts 
or ×fin.3= peptlcl¢= were mixed with I0 all or the labeled B.block 
oligonucl¢otlde If) a final volume of 14 /~1, D-~Ia )'or the 
Zna'-containing (l-anes I-4} =rod Zn='.free r.eptide (lanes S-8) are 
shown, The ratios or n. ") of pepcide per mol or DNA base pairs were: 
lane 1, 0:1 ; lane 2. 4: I; lane 3, 12:1: lane 4, 40:l; lane 5, 0:1; lane 6, 
0,3:1 ; lane 7, 4: |; lane 8, 40:1, The nutoradiogram el'the gel is shown, 
increasing amounts of Zn z+ finger peptide, the labeled 
oligonucleotide is retarded in its migration in the gel, in- 
dicating an interaction with the peptide. Binding assays 
were performed, giving an association constant of 1.5 
× I0 6 M' l l  The diffuse nature of the retarded species 
and the absence of specific retarded bands suggests a
non-specific interaction of the peptide and the labeled 
DNA. Similar results were obtained for the TFIIIA 
oligonucleotide and for a non-specific restriction frag- 
ment from pUCl9 (data not shown). In the absence of 
Zn 2+ (Fig. 3, lanes 5 to 8), no retardation of the 
oligonucleotide is observed, even with 40-fold excess of 
peptide to DNA base pairs suggesting that Zn 2÷ is re- 
quired for DNA binding. It is clear from Fig. 3 that the 
zinc finger peptide binds to both single stranded and 
double stranded DNA; this is not surprising since intact 
TFIIIA is also known to bind single stranded DNA [31]. 
In order to determine whether the binding of the X fin 
peptide xhibits any sequence specificity, binding to the 
labeled oligonucleotide was challenged by the inclusion 
of various amounts of unlabeled poly dl-po[y dC as a 
competitor. Fig. 4 shows that poly dl.poly dC competes 
effectivelywith the labeled oligonucleotide for peptide 
binding. From the competition experiments, the ap- 
parent association constant for Xfin-31 peptide binding 
to poly dl-poly dC is 9.4 x IO s M- ~ and the active pep- 
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Fit=• 4. Poly dl.poly dC competition for Xtin-3l I'~pdde bindinti to a 
labeled double stranded eoxycdiiionu¢lemide. (a) In Inner I to ~, I nit 
(16 pmol base pairs) or labeled B.bloek ollilonucleolltle was mixed 
with inereaslfl$ amount~ or zinc.containing Xfin41 pcptide while In 
lanes 6to 10, a constant amount or peptld¢ t0,6 nmoll. I nil of labeled 
DNA (16 DroOl) and various amounts or unlabeled poly dl.poly dC 
were analyzed by non.denaturlnlt gel ele¢trophoresl~. The ratios or 
reel of peptlde to total reel or DNA base p~lrs were: lane I, 0:1 ~ lane 
2, 0,26:1; lane 3, 0,8:1. lane 4, 5:1; lane ~, l?:l; lane 6, 36:1t lane 7, 
6:1; lane 8, 3:1; hme 9, I At:I; lane 10.0,?$,1, The autoradiosram or 
the gel is shown. (b} A plot or the ratio or hound tc free labeled 
oligonucleotide versus total input DNA concentration, Data were ot~. 
rained with a constant amount of peptide ($5/~M concentration), I n~, 
(16 pmol] labeled DNA and Increasinit amounts of unlabeled poly di. 
poly de, Data are included from tltree separate xperiments, TIle ap. 
parent association constant rot the DNA.peptid¢ complex it 
calculated from the slope and the active pcptide concentration from 
the x.intercept. 
tide concentration is 14.0 + 1,5 ,#M, assuming that the 
binding site for the peptide is I base pair (as the com. 
petitor concentration is given in molar base pairs). The 
actual peptide concentration used in this experiment 
was 55 aM. Previous NMR studies [10,11] indicated 
that the Xfin-31 peptide is structurally homogeneous 
and have inferred that essentially all the peptide is active 
in binding DNA. Using this peptide concentration, the 
interaction of Xfin-31 with DNA was determined tobe 
3.9 ± 0.4 base pairs (55/2M/14 ± 1.S,uM). Within ex- 
perimental uncertainty, these data suggest that the 
Xfin-31 peptide interacts with about 4 bp of DNA. 
There have been other reports of DNA binding by 
single zinc finger peptides. The second zinc finger from 
TFIIIA appears to bind to DNA with some sequence 
specificity; however, binding showed no clear 
dependence on Zn 2÷ [6]. (Our own experiments with a 
zinc finger peptide corresponding to finger 5 of TFIIIA 
fail to detect any specificity in binding to an 
oligonucleotide containing the correct recognition site). 
A single zinc finger from ADR1 binds non-specifically 
to DNA; the affinity is increased in the presence of 
Zn 2+ [7]. In both cases, folding of the peptide is depen- 
dent on the presence of Zn 2+. However, a zinc finger 
motif from mKr2 was reported recently to adopt a 
stable tertiary structure in aqueous solution in the 
absence of Zn 2+ [15]. Although both zinc-free Xfin-31 
and de-metallated SWI5 do not show any long-range 
NOE's ,  the free mKr2 peptide has been reported to 
show a number o f '  /, range NOE's  indicative o f  fold. 
ed structure, in contrast, the chemical shifts reported 
for mKr2 closely resemble those e ta  ' random coil '  [32]; 
in fact, the chemical shift dispersion of the fingerprint 
region of the NOESY spectrum of  inK, r2 [IS] closely 
resembles that of  the unfolded zinc-free Xfin-31 
(Fig. I) .  
4, CONCLUSION 
For ~ sinlle synthetic zinc finger of the TFIIIA type, 
Xfin-31, NMR experiments show unequivocally tli~t 
~.itt¢ is required for correct folding and that the zinc-free 
peptide is not folded in a stable tertiary conformation• 
Since the peptide is largely unfolded in the absence of 
Zn 2., the metal appears to play a key role in stabiliza- 
tion of the folded structure, Cortcordantly, DNA bin- 
ding assays clearly indicate that the Xfin-3l peptide 
binds to DNA (non-specifically) only in the presence of 
Zn 2+. These assays further support he NMR evidence 
for the correct folding of the Xfin-31 peptide in the 
presence of Zn v', 
One of the more interesting results of the DNA bin- 
ding experiments is the apparent number of base pairs 
that interact with the Xfin-31 peptide. Our experimen- 
tal data suggest that about 4 bp of DNA interact with 
the folded Xl'in zinc finger. We note that - 5 base pairs 
per finger a're implicated in binding of TFII IA and 
SWI5 to DNA [1,33,34], while binding of SDI fingers is 
believed to involve - 3 base pairs per finger [35]. Thus 
there may be differences in the mode of interaction of 
zinc fingers with DNA, depending on whether the bin- 
ding is specific or non-specific and upon the exact 
nature of the zinc fingers and the target DNA. Elucida- 
tion of these interactions will require direct structural 
studies of DNA-zinc finger complexes, which are cur- 
rently in progress in this laboratory. 
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